In 2009, the Clinical Pharmacogenetics Implementation Consortium (CPIC, www. cpicpgx.
org), a shared project between Pharmacogenomics Knowledge Base (PharmGKB …

The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly
due to the lack of specific guidelines on how to adjust medications on the basis of the …

Abstract The Clinical Pharmacogenetics Implementation Consortium (CPIC) publishes
genotype-based drug guidelines to help clinicians understand how available genetic test …

Numerous pharmacogenetic clinical guidelines and recommendations have been
published, but barriers have hindered the clinical implementation of pharmacogenetics. The …

Purpose The current state of pharmacogenetic data curation and dissemination is described,
and evidence-based resources for applying pharmacogenetic data in clinical practice are …

The evidence for pharmacogenetics has grown rapidly in recent decades. However, the
strength of evidence required for the clinical implementation of pharmacogenetics is highly …

The pace of discovery of potentially actionable pharmacogenetic variants has increased
dramatically in recent years. However, the implementation of this new knowledge for …

The clinical implementation of pharmacogenetic biomarkers continues to grow as new
genetic variants associated with drug outcomes are discovered and validated. The number …

Testing, reporting and translation of pharmacogenetics (PGx) into clinical recommendations
requires vast knowledge resources. The Pharmacogene Variation (PharmVar) Consortium …

Considerable efforts have been exerted to implement Pharmacogenomics (PGx), the study
of interindividual variations in DNA sequence related to drug response, into routine clinical …